Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
24.98
-1.96 (-7.28%)
Jun 12, 2026, 4:00 PM EDT - Market closed

COAG Statistics

Total Valuation

COAG has a market cap or net worth of $1.10 billion. The enterprise value is $919.72 million.

Market Cap1.10B
Enterprise Value 919.72M

Important Dates

The last earnings date was Thursday, May 21, 2026, before market open.

Earnings Date May 21, 2026
Ex-Dividend Date n/a

Share Statistics

COAG has 44.19 million shares outstanding.

Current Share Class 44.19M
Shares Outstanding 44.19M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.28%
Owned by Institutions (%) 13.30%
Float 21.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 6.01
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.03, with a Debt / Equity ratio of 0.01.

Current Ratio 18.03
Quick Ratio 17.62
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -46.99% and return on invested capital (ROIC) is -31.85%.

Return on Equity (ROE) -46.99%
Return on Assets (ROA) -30.11%
Return on Invested Capital (ROIC) -31.85%
Return on Capital Employed (ROCE) -38.09%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.08M
Employee Count 59
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -227,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 37.22
Average Volume (20 Days) 168,267

Short Selling Information

The latest short interest is 1.03 million, so 2.32% of the outstanding shares have been sold short.

Short Interest 1.03M
Short Previous Month 758,697
Short % of Shares Out 2.32%
Short % of Float 4.82%
Short Ratio (days to cover) 1.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -70.12M
Pretax Income -64.14M
Net Income -63.91M
EBITDA -69.82M
EBIT -70.12M
Earnings Per Share (EPS) -$67.56
Full Income Statement

Balance Sheet

The company has $185.49 million in cash and $1.27 million in debt, with a net cash position of $184.22 million or $4.17 per share.

Cash & Cash Equivalents 185.49M
Total Debt 1.27M
Net Cash 184.22M
Net Cash Per Share $4.17
Equity (Book Value) 183.53M
Book Value Per Share -186.72
Working Capital 181.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$61.48 million and capital expenditures -$16,000, giving a free cash flow of -$61.49 million.

Operating Cash Flow -61.48M
Capital Expenditures -16,000
Depreciation & Amortization 304,000
Net Borrowing -120,000
Free Cash Flow -61.49M
FCF Per Share -$1.39
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

COAG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -5.79%
FCF Yield -5.57%

Analyst Forecast

The average price target for COAG is $41.75, which is 67.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $41.75
Price Target Difference 67.13%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1